COVID19 news

Supporting research at Cambridge University Hospitals

As the COVID-19 situation develops, research staff at CUH continue our support of COVID-19 research studies, including Urgent Public Health Studies (UPH), while maintaining safe recruitment to existing open studies. Read more

Punctured lung affects almost one in a hundred hospitalised COVID-19 patients

As many as one in 100 patients admitted to hospital with COVID-19 develop a pneumothorax – a ‘punctured lung’ according to a study supported by the NIHR Cambridge BRC. Read more

New research shows steroid improves survival of critically ill Covid-19 patients

New research published has been able to show that using the steroid hydrocortisone on patients with severe COVID-19 symptoms improves their recovery.Read more

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

Cambridge University Hospitals has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.Read more

TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19

As part of a new trial, a microbe will be used to treat severe COVID-19 in an experimental drug known as EDP1815. Read more

Rapid COVID-19 test halves patient waiting times

A new diagnostic test that can diagnose COVID-19 in a hospital setting faster than standard testing methods has been able to halve patients waiting times.Read more

Cambridgeshire Trusts join COVID-19 vaccine trial

Three leading NHS Trusts in Cambridgeshire are collaborating on a COVID-19 vaccine trial which has been developed by the University of Oxford.Read more

Cambridge study to trial widely used drug to protect healthcare staff from COVID-19.

The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more

Over 150 participants recruited to new COVID-19 research programme

A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.Read more

Cambridge trial targets immune response to treat COVID-19 patients

A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more

NIHR Cambridge BRC and CRF begin working on new COVID-19 study

Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a research trial into COVID-19.Read more

Fast-track HRA review of COVID-19 studies

The Health Research Authority (HRA) is working with the rest of the research system to provide a coordinated process so that COVID-19 research can progress quickly, using a fast-track review process with bespoke Read more

Discover more

If you would like more information about NIHR Cambridge BRC, please contact us.

Events Calendar

Listing relevant events and training sessions for researchers and members of the public.